uniQure Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

XTRA:UQ1 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Feb 24	Sell€163,334	Matthew Kapusta	Individual	27,904	€5.85
26 Feb 24	Sell€93,545	Christian Klemt	Individual	15,906	€5.88
26 Feb 24	Sell€56,390	Pierre Caloz	Individual	9,455	€5.96
18 Sep 23	Sell€40,794	Ricardo Dolmetsch	Individual	5,841	€6.98
16 Jun 23	Sell€39,508	Jeremy Springhorn	Individual	2,286	€17.28
16 Jun 23	Sell€27,515	Christian Klemt	Individual	1,587	€17.34
16 Jun 23	Sell€50,252	Pierre Caloz	Individual	2,920	€17.21
16 Jun 23	Sell€39,519	Madhavan Balachandran	Individual	2,283	€17.31
16 Jun 23	Sell€55,789	Robert Gut	Individual	3,228	€17.28
16 Jun 23	Sell€39,509	Jack Kaye	Individual	2,280	€17.33
16 Jun 23	Sell€39,515	David Meek	Individual	2,290	€17.26
16 Jun 23	Sell€39,490	Leonard Post	Individual	2,291	€17.24
16 Jun 23	Sell€39,547	Paula Soteropoulos	Individual	2,275	€17.38
16 Jun 23	Sell€39,515	Rachelle Jacques	Individual	2,301	€17.17

Insider Trading Volume

Insider Buying: UQ1 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of UQ1?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	393,072	0.841%
General Public	1,454,794	3.11%
Public Companies	2,388,108	5.11%
Hedge Funds	9,304,875	19.9%
Institutions	33,188,228	71%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.5%	BlackRock, Inc.	4,898,640	€94.3m	13.9%	no data
8.18%	Point72 Asset Management, L.P.	3,820,807	€73.5m	17.5%	0.2%
6.61%	Nantahala Capital Management, LLC	3,090,757	€59.5m	9.93%	4.99%
5.96%	FMR LLC	2,786,683	€53.6m	-26.5%	no data
5.12%	PFM Health Sciences, LP	2,393,311	€46.1m	7.02%	1.79%
5.11%	Bristol-Myers Squibb Company	2,388,108	€46.0m	0%	no data
5.06%	State Street Global Advisors, Inc.	2,365,144	€45.5m	-15.9%	no data
2.9%	683 Capital Management, LLC	1,355,000	€26.1m	0%	1.91%
2.77%	The Vanguard Group, Inc.	1,292,622	€24.9m	6.84%	no data
2.72%	Morgan Stanley, Investment Banking and Brokerage Investments	1,271,718	€24.5m	-7.42%	no data
2.08%	Aquilo Capital Management, LLC	971,490	€18.7m	7.76%	8.43%
1.87%	OrbiMed Advisors LLC	874,849	€16.8m	-4.83%	0.28%
1.57%	J.P. Morgan Asset Management, Inc.	734,127	€14.1m	-7.58%	no data
1.53%	Balyasny Asset Management L.P.	713,240	€13.7m	192%	0.06%
1.51%	Macquarie Investment Management Business Trust	707,141	€13.6m	0.14%	0.01%
1.46%	Holocene Advisors, LP	680,653	€13.1m	0%	0.08%
1.21%	Marshall Wace LLP	566,645	€10.9m	0%	0.03%
1.17%	Forbion Capital Partners B.V.	546,166	€10.5m	0%	7.44%
1.12%	Tekla Capital Management LLC	521,693	€10.0m	0%	0.38%
1.08%	AllianceBernstein L.P.	505,156	€9.7m	54.3%	no data
1.03%	Columbia Management Investment Advisers, LLC	479,248	€9.2m	-1.72%	no data
1.02%	T. Rowe Price Group, Inc.	475,917	€9.2m	44.1%	no data
0.96%	SV Health Investors, LLC	446,500	€8.6m	187%	2.12%
0.88%	Norges Bank Investment Management	411,371	€7.9m	0%	no data
0.87%	Hudson Bay Capital Management LP	405,000	€7.8m	20.9%	0.1%